Millions of U.S. men over 55 at risk for missed prostate cancer screenings

COLUMBIA, Md., Sept. 1, 2026 /CourierPR/ -- Millions of men over 55 in the U.S. are at risk of missing crucial prostate cancer screenings, according to a new national survey conducted by MedStar Health. The findings highlight a concerning gap in preventive healthcare that could have significant implications for men's health.

Among the surveyed men aged 55 and older, a staggering 30% reported never having undergone a prostate exam, while nearly 40% admitted to not having received a prostate-specific antigen (PSA) blood test, a key indicator for prostate cancer. These statistics underscore a potential public health crisis, given that prostate cancer is one of the most prevalent cancers among men.

Dr. Jonathan J. Hwang, chair of Urology at MedStar Washington Hospital Center, emphasized the importance of regular screenings. "Prostate cancer can be common, and early signs may not be apparent," he said. "Many men may be postponing or unaware of the signs to look out for."

The survey also revealed that about one in eight men will eventually be diagnosed with prostate cancer during their lifetime. While 41% of the surveyed men know someone who has had the disease, only 6% were aware of all the symptoms, including difficulty with urination, blood in urine or semen, fatigue, and pain in the lower back, hips, or thighs.

Patient Jack Chungo's experience offers a stark reminder of the importance of early detection. Diagnosed after noticing a significant drop in energy levels and unexpected weight loss, Chungo was found to have a PSA level about ten times higher than normal. After treatment with hormone therapy and CyberKnife® radiation at MedStar Georgetown University Hospital, he is now in remission.

"Early detection is crucial," Chungo stated. "If you suspect anything, it’s important to discuss it with your doctor. Earlier screening can make a big difference."

MedStar Health's research further indicates that prostate cancer risk is influenced by factors such as family history, genetic predisposition, and racial background, with Black men facing a higher risk. For men at increased risk, screenings are recommended to begin between the ages of 40 and 45.

Dr. Stephen Ronson, medical director of Radiation Oncology at MedStar Franklin Square Medical Center, stressed the importance of proactive communication between patients and healthcare providers. "Men should feel comfortable discussing their risk factors and symptoms with their doctor," he said. "This can help ensure they receive appropriate screening and treatment."

The survey results highlight the necessity for increased awareness and advocacy around prostate cancer screening among men over 55. MedStar Health encourages men to take charge of their health by consulting their doctors about their individual risk factors and the timing of their next screening.